And finally.......... on 10 October 2023 the Directors of Quantexa admit they lied and that its Series E did not complete as advertised - but it is much worse than that.
Once more, as with the never completed Series D, the directors of Quantexa are shown to be living in a mythical world of unicorns and once more deceiving the public, their clients and their investors.
The records of Companies House show a filing made on 10 October 2023 stating that 109,036 Series E Preference shares were issued between 19 April and 16 June at a price of £733.7 per share. That is an implied total of US$100,000,000 - some 30% less than advertised even if it was true.
That simply cannot be the case. The records of Companies House show that the directors had, and still have, no lawful authority to issue any shares.
Also if any Series E shares had been issued then the Auditors were required to ensure it was disclosed in the late filed accounts which they approved on 17 July when they knew the statements in the Directors report and Note 28 of the accounts were wholly false and untrue.
What does Colin Bell, CEO of HSBC Bank plc think he is doing? His entire background is compliance.
It is time for a Department of Trade and Business investigation under s.432 Companies Act 1985.
Only one problem .......... the Secretary of State, Rt. Hon. Kemi Badenoch MP, is a party to the scam as a result of her department's ownership of a considerable investment in Quantexa via British Patient Capital Ltd. that confirms the veracity of many of the statements made in this post.
Comments
Post a Comment